VitaDX

About:

VitaDX develops a non-invasive solution for early bladder cancer diagnosis.

Website: http://vitadx.com/en/

Twitter/X: vitadx_sa

Top Investors: BNP Paribas, GO CAPITAL, WILCO, ODYSSEE VENTURE, Auriga Partners

Description:

VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample to improve the performance of urinary cytology conventionally used in first intention.